Author:
Xing Hao,Huang Yaqing,Kunkemoeller Britta H.,Dahl Peter J.,Muraleetharan Ohvia,Malvankar Nikhil S.,Murrell Michael P.,Kyriakides Themis R.
Abstract
AbstractFibroblasts are a major cell population that perform critical functions in the wound healing process. In response to injury, they proliferate and migrate into the wound space, engaging in extracellular matrix (ECM) production, remodeling, and contraction. However, there is limited knowledge of how fibroblast functions are altered in diabetes. To address this gap, several state-of-the-art microscopy techniques were employed to investigate morphology, migration, ECM production, 2D traction, 3D contraction, and cell stiffness. Analysis of cell-derived matrix (CDM) revealed that diabetic fibroblasts produce thickened and less porous ECM that hindered migration of normal fibroblasts. In addition, diabetic fibroblasts were found to lose spindle-like shape, migrate slower, generate less traction force, exert limited 3D contractility, and have increased cell stiffness. These changes were due, in part, to a decreased level of active Rac1 and a lack of co-localization between F-actin and Waskott-Aldrich syndrome protein family verprolin homologous protein 2 (WAVE2). Interestingly, deletion of thrombospondin-2 (TSP2) in diabetic fibroblasts rescued these phenotypes and restored normal levels of active Rac1 and WAVE2-F-actin co-localization. These results provide a comprehensive view of the extent of diabetic fibroblast dysfunction, highlighting the regulatory role of the TSP2-Rac1-WAVE2-actin axis, and describing a new function of TSP2 in regulating cytoskeleton organization.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Wang, L. et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999–2018. JAMA 326, 704–716 (2021).
2. Yang, W. et al. Economic costs of diabetes in the US in 2017. Diabetes Care 41, 917–928 (2018).
3. Reiber, G. E. et al. Causal pathways for incident lower-extremity ulcers in patients. Diabetes Care 22, 157–162 (1999).
4. Bao, P. et al. The role of vascular endothelial growth factor in wound healing. J. Surg. Res. 153, 347–358 (2009).
5. Kolluru, G. K., Bir, S. C. & Kevil, C. G. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 526 (2012).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献